Watch Demo

Latvia Lipid Modifying Drug Industry Outlook 2022 - 2026

See how Latvia Lipid Modifying Drug performed compared to key markets such as South Korea, Spain and Italy.

Key Market Indicators

Sales of lipid-modifying medicines in Latvia are set to reach around $12 million by 2026. The market has grown by an average of 2% each year since 2006; in 2021, it was valued at $11 million. Latvia ranked 21st in the world, with Slovenia overtaking it with sales of $11 million. Spain, Italy and Germany came in second, third and fourth place respectively.

Marketing Banner

Latvia Lipid Modifying Drug Market Data and Forecasts

How much will Latvia Lipid Modifying Drug Market grow to 2026?

Forecast: Lipid Modifying Medicine Sales in Latvia
Forecast: Lipid Modifying Medicine Use in Latvia
Forecast: Lipid Modifying Medicine Sales in Latvia
Forecast: Lipid Modifying Medicine Sales in Latvia
Forecast: Lipid Modifying Medicine Sales in Latvia
More in Lipid Modifying Drug Industry for 2028